Tilray Brands Inc vs T Rowe Price Group Inc — how do they compare? Tilray Brands Inc trades at $3.64 (market cap $549.01M), while T Rowe Price Group Inc trades at $104.25 (market cap $22.20B). The key difference: T Rowe Price Group Inc is far larger — about 40.4× Tilray Brands Inc's market cap, and T Rowe Price Group Inc pays a 5% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and T Rowe Price Group Inc for 115 Days on average.
| TLRY | TROW | |
|---|---|---|
Market Cap | $549.01M | $22.20B |
Volume | 3,292,073 | 1,738,431 |
Sector | Health | Financials |
52-Week High | $21.00 | $121.68 |
52-Week Low | $3.57 | $86.19 |
Typical Hold Time | 31 Days | 115 Days |
Enterprise Value | $716.15M | $19.39B |
Dividend Yield | — | 5% |
Signals from Pluang's Aura AI — not financial advice
Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.
While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.
T. Rowe Price (TROW) trades at $104.23, up 0.61% with bearish technical signals but strong fundamentals including a 29.26% net margin and $2.09B net income. The stock shows consistent earnings beats and dividend growth, supported by $1.90 trillion in assets under management as of August 2026. Recent news highlights dividend sustainability and ETF expansion through acquisitions.
Outlook remains positive with a $112 consensus price target offering 7.5% upside, though technical weakness and market volatility pose near-term risks. The company's 40-year dividend growth history and expanding product portfolio provide stability, while net outflows and competitive pressures require monitoring for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →